Search clinical trials for: renal impairment,

Total 21064 results

Universidade do Porto

Unknown

Multiple Interventions to Prevent Cognitive Decline (MIND)

Cognitive Dysfunction | Cognition Disorders | Memory Disorders

Portugal
Pfizer

Completed

PF-04634817 Renal Impairment Study

Renal Insufficiency

United States
Astellas Pharma Inc

Completed

Renal Impairment Study With ASP1941

Type 2 Diabetes Mellitus

Hungary, Poland, Czechia, Slovakia
Technische Universität Dresden

Terminated

Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases (RadioCoBRIM)

Brain Metastases | Malignant Melanoma Stage IV | BRAF V600 Mutation

Germany
Novartis Pharmaceuticals

Completed

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Mild and Moderate Renal Impairment

Russian Federation, Germany, Serbia
Region Skane
Lund University; Berry Lab

Completed

Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment (MINDBERRY)

Memory Impairment | Cognitive Impairment, Mild

Sweden
Stanford University

Recruiting

CogT pSOPT Intervention Study

Mild Cognitive Impairment | Subjective Cognitive Impairment

United States
Merck Sharp & Dohme LLC

Completed

Belzutifan (MK-6482) Hepatic Impairment Study (MK-6482-020)

Moderate Hepatic Impairment

United States
EQRx International, Inc.

Completed

An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143

Severe Hepatic Impairment

United States
Pfizer

Completed

Evaluate Severe Hepatic Impairment on Dacomitinib PK

Severe Hepatic Impairment

United States
Takeda

Completed

Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic Impairment

Severe Hepatic Impairment

United States
Takeda

Completed

Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic Impairment

Renal Impairment | Hepatic Impairment

Japan
Fondazione Don Carlo Gnocchi Onlus
University of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...

Completed

Cognitive and Physical Home-rehabilitation by Information and Communications Technology. Games for Older Adults Active Life (GOAL) (GOAL)

Cognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive Impairment

Italy
Agios Pharmaceuticals, Inc.

Completed

A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function

Moderate Hepatic Impairment

United States
University of California, Los Angeles

Completed

18-Month Study of Memory Effects of Curcumin (Curcumin)

Mild Cognitive Impairment (MCI) | Age-associated Cognitive Impairment

United States
Merck Sharp & Dohme LLC

Not yet recruiting

A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)

Hepatic Impairment (HI)
Bausch Health Americas, Inc.

Terminated

Steady-State Pharmacokinetics of Rifaximin 550 mg Tablets in Healthy and Hepatically Impaired Subjects

Severe Hepatic Impairment

United States
KBP Biosciences
Covance

Completed

Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment

Healthy | Moderate Hepatic Impairment

United States
Tibotec BVBA

Completed

A Study of TMC207 in Patients With Moderately Impaired Hepatic Function

Moderate Hepatic Impairment
Wuhan Union Hospital, China

Completed

Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis (CSODITTOKO)

Knee Osteoarthritis

China
Center for Studies of Sensory Impairment, Aging...
Hildegrad Grunow Foundation; MBR Optical Systems

Completed

Non-invasive Determination of Anemia in Children With Renal Failure

Renal Failure
Bayer

Completed

Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")

Prevention of Thromboembolic Events

Germany
Merck KGaA, Darmstadt, Germany

Completed

Pharmacokinetics in Subjects With Renal Impairment

Renal Impairment

Germany
Pfizer

Completed

Bosutinib In Subjects With Renal Impairment

Renal Insufficiency, Chronic | Renal Insufficiency, Acute | Renal Disease, End-Stage

United States
Universidad de Zaragoza

Recruiting

Effects of a Computerised Cognitive Stimulation Versus Stimulating Leisure Activities

Mild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive Impairment

Spain
Vanderbilt University
Tennessee Department of Education

Recruiting

Providing Access to the Visual Environment

Vision Impairment

United States
University of California, San Francisco
Federal University of Minas Gerais

Completed

Better Memory With Literacy Acquisition Later in Life

Memory Impairment

Brazil
Sunshine Lake Pharma Co., Ltd.

Completed

To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects

Hepatic Impairment

China
Westat
United States Social Security Administration

Completed

Supported Employment Demonstration (SED)

Mental Impairment

United States
Eisai Inc.
Eisai Limited

Completed

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Attention Impairment

United States, Netherlands, France, Spain, United Kingdom, Germany, Argentina, Canada, Australia, Chile
Loewenstein Hospital

Completed

Differences in Muscle Activity Patterns and Graphical Product Quality in Children With Graphomotor Impairment

Graphomotor Impairment

Israel
Porter Adventist Hospital

Terminated

Donepezil Memory Preservation Post ECT

Memory Impairment

United States
Janssen Research & Development, LLC

Withdrawn

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic Function

Hepatic Impairment
Stanford University
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

Age-related Longitudinal Changes in Aviator Performance

Memory Impairment

United States
US Department of Veterans Affairs

Completed

Restricted Useful Field View as a Risk Factor in Older Adults

Vision Impairment

United States
Bracco Diagnostics, Inc

Completed

Patients With Renal Impairment Undergoing CT

Contrast Induced Nephropathy

United States
Shaare Zedek Medical Center

Completed

Renal Impairment Associated With Colistin Levels

Sepsis

Israel
Mitsubishi Tanabe Pharma Corporation

Completed

PK Study in Subjects With Severe Hepatic Impairment (MCI-186-E05 HP)

Healthy | Severe Hepatic Impairment

Czechia, Hungary, Slovakia
Astellas Pharma Global Development, Inc.

Completed

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215

Healthy | Hepatic Impairment

United States
VA Office of Research and Development

Not yet recruiting

User Evaluation of Advanced Personalized Modular Pressure Relief Seating Cushion Systems (Squishycushion)

Mobility Impairment

United States
Shire

Completed

Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants

Hepatic Impairment

United States
Ufuk University

Completed

Effects of Single-task Versus Dual-task Training on balancePERFORMANCE

Balance Impairment
Dr. Jose Antonio SERRA-REXACH
Instituto de Salud Carlos III

Completed

Physical Training in Hospitalized Elderly (AGECAR)

Functional Impairment

Spain
David Merrill, MD, PhD

Completed

Memory and Exercise Training Study in Older Adults With Subjective Memory Complaints (MET)

Memory Impairment

United States
Neurolgy Institute for Brain Health and Fitness
DSM Nutritional Products, Inc.

Unknown

Cerebrovascular and Cognitive Improvement by Resveratrol (resVida) and Fruitflow-II (CCIRF-II) (CCIRF-II)

Memory Impairment

United States
Pfizer

Completed

Renal Impairment Study of PF-06700841

Renal Impairment | Healthy Volunteer

United States
Bayer

Completed

Hepatic Impairment Study

Liver Disease

United States
Jazz Pharmaceuticals

Completed

Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients

Hepatic Impairment

United States
Yale University

Completed

The Effects of Minocycline in Humans

Memory Impairment

United States
Seagen Inc.

Completed

A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects

Hepatic Impairment

United States

Search clinical trials for: renal impairment,

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations